Wealth Enhancement Advisory Services, LLC Charles River Laboratories International, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49 Billion
- Q1 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 5,723 shares of CRL stock, worth $779,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,723
Previous 5,970
4.14%
Holding current value
$779,758
Previous $1.1 Million
21.87%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding CRL
# of Institutions
649Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$832 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$693 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$584 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$326 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$266 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $6.93B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...